#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA2150443	B	Inhibition of TLR2/TLR6 in FSL1-stimulated mouse RAW264.7 cells at 0.6 uM after 24 hrs	Mus musculus	1		cell-based format	Scientific Literature
2.	ALA3111193	B	Inhibition of TLR2/6-mediated NFkappaB p65 activation in BLP-stimulated BALB/c mouse BMDM at 5 ug/ml preincubated for 18 hrs followed by BLP challenge measured after 1 hr by TransAM ELISA	Mus musculus	2		protein complex format	Scientific Literature
3.	ALA3111194	B	Inhibition of TLR2/6 in BALB/c mouse BMDM assessed as downregulation of BLP-stimulated IL-6 level at 5 ug/ml preincubated for 18 hrs followed by BLP challenge measured after 24 hrs by ELISA relative to control	Mus musculus	110		protein complex format	Scientific Literature
4.	ALA3111195	B	Inhibition of TLR2/6 in BALB/c mouse BMDM assessed as downregulation of BLP-stimulated IL-12p40 level at 5 ug/ml preincubated for 18 hrs followed by BLP challenge measured after 24 hrs by ELISA relative to control	Mus musculus	110		protein complex format	Scientific Literature
5.	ALA3881377	B	Antagonist activity at TLR2/6 in mouse RAW264.7 cells assessed as inhibition of FSL-1-induced receptor activation by measuring NO production at 3 uM after 24 hrs	Mus musculus	1		cell-based format	Patent Bioactivity Data
6.	ALA3881381	B	Antagonist activity at TLR2/6 in mouse RAW264.7 cells assessed as inhibition of FSL-1-induced receptor activation by measuring NO production at 0.5 uM after 24 hrs	Mus musculus	1		cell-based format	Patent Bioactivity Data
7.	ALA4222362	B	Antagonist activity at TLR2/TLR6 in mouse Raw 264.7 cells assessed as decrease in Pam2CSK4-induced iNOS levels at 40 uM after 24 hrs relative to positive control	Mus musculus	1		cell-based format	Scientific Literature
8.	ALA4361580	B	Antagonist activity at TLR2/6 in mouse RAW264.7 cells assessed as reduction in FSL-1-induced TNFalpha secretion at 20 to 80 uM after 24 hrs by ELISA	Mus musculus	1		cell-based format	Scientific Literature
9.	ALA5105459	B	Agonist activity at TLR2/TLR6 in C57BL/6 mouse spleen B cells assessed as increase in CD40 expression at 10 to 0.1 ug/ml incubated for 24 hrs by fluorescence based flow cytometric analysis	Mus musculus	6		tissue-based format	Scientific Literature
10.	ALA5105460	B	Agonist activity at TLR2/TLR6 in C57BL/6 mouse spleen B cells assessed as increase in CD86 expression at 10 to 0.1 ug/ml incubated for 24 hrs by fluorescence based flow cytometric analysis	Mus musculus	3		tissue-based format	Scientific Literature
11.	ALA5105461	B	Agonist activity at TLR2/TLR6 in C57BL/6 mouse spleen dendritic cells assessed as increase in CD40 expression at 10 to 0.1 ug/ml incubated for 24 hrs by fluorescence based flow cytometric analysis	Mus musculus	6		tissue-based format	Scientific Literature
12.	ALA5105462	B	Agonist activity at TLR2/TLR6 in C57BL/6 mouse spleen dendritic cells assessed as increase in CD86 expression at 10 to 0.1 ug/ml incubated for 24 hrs by fluorescence based flow cytometric analysis	Mus musculus	3		tissue-based format	Scientific Literature
13.	ALA5105463	B	Agonist activity at TLR2/TLR6 in C57BL/6 mouse spleen B cells assessed as increase in CD40 expression incubated for 24 hrs by fluorescence based flow cytometric analysis	Mus musculus	2		tissue-based format	Scientific Literature
14.	ALA5105464	B	Agonist activity at TLR2/TLR6 in C57BL/6 mouse spleen B cells assessed as increase in CD86 expression incubated for 24 hrs by fluorescence based flow cytometric analysis	Mus musculus	2		tissue-based format	Scientific Literature
15.	ALA5105465	B	Agonist activity at TLR2/TLR6 in C57BL/6 mouse spleen dendritic cells assessed as increase in CD40 expression incubated for 24 hrs by fluorescence based flow cytometric analysis	Mus musculus	2		tissue-based format	Scientific Literature
16.	ALA5105466	B	Agonist activity at TLR2/TLR6 in C57BL/6 mouse spleen dendritic cells assessed as increase in CD86 expression incubated for 24 hrs by fluorescence based flow cytometric analysis	Mus musculus	2		tissue-based format	Scientific Literature